- 2022.
- 2021.
- 2020.
- 2019.
- 2018.
- 2017.
- 2016.
- 2015.
- 2014.
- 2013.
- 2012.
- 2011.
- 2010.
- 2009.
- 2008.
- 2007.
- 2006.
- 2005.
- 2004.
- 2003.
- 2002.
- 2001.
- 2000.
- 1999.
- 1998.
- 2022.
- 2021.
- 2020.
- 2019.
- 2018.
- 2017.
- 2016.
- 2015.
- 2014.
- 2013.
- 2012.
- 2011.
- 2010.
- 2009.
- 2008.
- 2007.
- 2006.
- 2005.
- 2004.
- 2003.
- 2002.
- 2001.
- 2000.
- 1999.
- 1998.
2022.
-
- Jan.28.2022 R & D
- Gilead Announces Partial Clinical Hold for Studies Evaluating Magrolimab in Combination with Azacitidine
-
- Jan.25.2022 R & D
- Opdivo® Intravenous Infusion Approved for the First-line Treatment of Metastatic or Recurrent Non-squamous Non-small Cell Lung Cancer in Combination with Bevacizumab and Chemotherapy in Taiwan
-
- Jan.17.2022 Licensing
- Ono Expands Drug Discovery Collaboration with Neurimmune AG in the Field of Neurodegenerative Diseases
-
- Jan.05.2022 R & D
- Opdivo® Intravenous Infusion Approved for the Adjuvant Treatment of Esophageal Cancer or Gastroesophageal Junction Cancer in Taiwan
-
- Jan.05.2022 Management / Finance
- Ono Announces Status of Acquisition of Own Shares
(Acquisition of own shares under the Articles of Incorporation pursuant to the provision of Paragraph 2, Article 165 of the Companies Act)